Selecta Biosciences, Inc.
FORMULATIONS AND DOSES OF PEGYLATED URICASE
Last updated:
Abstract:
Provided herein are methods and compositions related to the administration of uricase compositions and compositions comprising synthetic nanocarriers comprising an immunosuppressant for the treatment of subjects, including subjects with hyperuricemia, gout or a condition associated with gout.
Status:
Application
Type:
Utility
Filling date:
6 Nov 2020
Issue date:
24 Jun 2021